[Edaily Reporter Hyera Lee ] ActRo(290740)announced on the 26th that it has begun securing its first mass-production orders from a client for key components of autonomous driving cameras used in North American finished vehicles. ActRo CI. (Photo courtesy of ActRo) The supplied items are core components for autonomous vehicle cameras and will be applied to three vehicle models. An ActRo official stated, “As the production of autonomous driving cameras expands, the supply of related components is also expected to continue growing over the medium to long term, with additional supply projected to more than triple annually,” adding, “This first mass-production supply is highly significant as it marks ActRo’s full-scale entry as a core player in the North American automotive autonomous driving value chain supply network.” Earlier this year, ActRo invested in new “fully automated production facilities covering the entire process” equipped with AI-based systems. After finalizing its autonomous driving camera component business at the end of last year, the company has moved seamlessly from establishing a fully automated production line—built using its proprietary technology—to mass production. The company reported that, as originally planned, it has completed production line setup for autonomous driving components, secured orders, and is set to begin successful initial mass production. Additionally, preparations for the mass production of humanoid-related components, scheduled for the second half of the year, are proceeding smoothly. Furthermore, the company plans to expand production capacity next year to accommodate increasing order volumes. An ActRo official stated, “We are making a leap beyond our existing mobile-centric business structure to become a Physical AI components company focused on autonomous driving and humanoids,” adding, “We plan to cultivate these new businesses as key mid- to long-term growth engines and new cash cows.”
This week (October 19–23), startups in various sectors—including accommodation solutions, AI video production, and digital healthcare—secured investments from venture capital (VC) firms and accelerato…
We’re in an era of recession-driven consumption, where we want a lot but our wallets are light. Our reporter personally tests and evaluates “value-for-money alternatives” that let you keep up with tre…
Korean small-cap pharma, biotech, and healthcare stocks moved in opposite directions on Oct. 22, as large-cap chipmakers weakened. Rokit Healthcare posted the steepest decline on the KOSDAQ, while in-…